Kalasekhar Vijayasekharan

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

British journal of haematology

Leukemia & lymphoma

Cytometry. Part B, Clinical cytometry

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Kasturba Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kasturba Medical College Sep 14 2019

India

Assistant professor :: Division of pediatric hematology oncology

Tata Memorial Hospital Aug 01 2018

India

Specialist Senior Registrar :: Department of Pediatric Oncology

Jawaharlal Institute of Post Graduate Medical Education Apr 28 2014 - Jan 31 2015

India

Senior resident :: Department of pediatrics

Publications

Thirumala Rupakumar, Ajay Sankar, Kalasekhar Vijayasekharan, Prasanth Varikkattu Rajendran, Guruprasad Chellapan Sojamani, Binitha Rajeswari, Manjusha Nair, Rakesh Anandarajan, Divya Dennis, Priyakumari Thankamony
Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. British journal of haematology 205 (1) (2024)
Thirumala Rupakumar, Ajay Sankar, Kalasekhar Vijayasekharan, Prasanth Varikkattu Rajendran, Guruprasad Chellapan Sojamani, Binitha Rajeswari, Manjusha Nair, Rakesh Anandarajan, Divya Dennis, Priyakumari Thankamony
Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India. British journal of haematology (2024)
Harish Varma Tandra, Thirumala Rupakumar, Kalasekhar Vijayasekharan, Prasanth V R, Guruprasad C S, Priya Kumari T
A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)-is it a cost-effective alternative? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (11) (2022)
Kalasekhar Vijayasekharan, Anand Kc, Maya Prasad, Chetan Dhamne, Nirmalya Roy Moulik, Tanuja Shet, Epari Sridhar, Siddhartha Laskar, Seema Kembhavi, Sneha Shah, Sumeet Gujral, Gaurav Narula, Shripad D Banavali
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India. Pediatric hematology and oncology 39 (5) (2022)
Kalasekhar Vijayasekharan, Gaurav Chatterjee, Subramaniam Ramanathan, Gaurav Narula, Prashant Ramesh Tembhare, Papagudi G Subramanian, Nikhil V Patkar, Sumeet Gujral, Dhanalaxmi Shetty, Shripad D Banavali
Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign? Cytometry. Part B, Clinical cytometry 100 (3) (2020)
Kalasekhar Vijayasekharan, Maya Prasad, Nirmalya D Pradhan, Deepa Phillip, Sumeet Gujral, Tanuja Shet, Epari Sridhar, Seema Kembhavi, Sneha Shah, Shripad D Banavali, Gaurav Narula
Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India. Leukemia & lymphoma 61 (4) (2019)

Kalasekhar Vijayasekharan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kalasekhar Vijayasekharan